Background: Trousseau's syndrome is a prothrombotic state associated with malignancy that is poorly understood pathophysiologically. Methodsand Results: Here we report studies on the blood of a 55-year-old man with giant-cell lung carcinoma who developed a severe form of Trousseau's syndrome. His clinical course was dominated by an extremely hypercoagulable state. Despite receiving potent antithrombotic therapy, he suffered eleven major arterial and venous thrombotic events over a 5 month period. We examined the patient's blood for tissue factor (TF), the major initiator of coagulation, and found its concentration in his plasma to be forty-one-fold higher than the mean concentration derived from testing of 16 normal individuals. Conclusion: Almost all of the TFin the patient's plasma was associated with cell-derived microvesicles, likely shed by the cancer cells. © 2007 International Society on Thrombosis and Haemostasis.
CITATION STYLE
Del Conde, I., Bharwani, L. D., Dietzen, D. J., Pendurthi, U., Thiagarajan, P., & López, J. A. (2007). Microvesicle-associated tissue factor and Trousseau’s syndrome. Journal of Thrombosis and Haemostasis, 5(1), 70–74. https://doi.org/10.1111/j.1538-7836.2006.02301.x
Mendeley helps you to discover research relevant for your work.